Skip to content
USAID: From The American People TB-DIAH: Tuberculosis Data, Impact Assessment and Communications Hub
  • Knowledge Hub
  • Data Hub
  • Home
  • About
    • Project Overview & Objectives
    • TB DIAH Team
  • Countries
    • Afghanistan
    • Bangladesh
    • Burma
    • Cambodia
    • DRC
    • Ethiopia
    • India
    • Indonesia
    • Kenya
    • Kyrgyz Republic
    • Malawi
    • Mozambique
    • Nigeria
    • Pakistan
    • Philippines
    • South Africa
    • Tajikistan
    • Tanzania
    • Uganda
    • Ukraine
    • Uzbekistan
    • Vietnam
    • Zambia
    • Zimbabwe
  • Tools
    • ARCAssessment of Data Collection, Reporting & Analysis Capacity
    • D2ACData-to-Action Continuum Toolkit
    • MESSAM&E and Surveillance Systems Assessment
    • PBMEFPerformance-Based M&E Framework
    • QTSAQuality of Tuberculosis Services Assessment
    • STEPSurveillance and TB M&E Strengthening Plan
  • Resources
    • Capacity Strengthening
    • Center of Excellence
    • e-Learning Courses
    • NTP Website Activity
    • Resource Library
  • News
    • TB DIAH Digest
    • Social Media
    • 2023 Union Conference
    • Webinars

Search Results for:

Combating Multidrug-Resistant Tuberculosis: Year Four of the National Action Plan Report

Author(s): U.S. Government
Year: 2021
Filed under: drug resistance, Drug-resistant TB, MDR, mdr-tb, multidrug-resistant TB, Report

Using mHealth to combat multidrug-resistant tuberculosis across Vietnam

Author(s): PATH
Year: 2017
Filed under: Brief, Guidance and Tools, mdr-tb, multidrug-resistant TB, Technology, Vietnam

Generic programmatic and clinical guide for the introduction of new drugs and shorter regimen for treatment of multi/extensively drug-resistant tuberculosis

Author(s): Challenge TB, KNCV Tuberculosis Foundation
Year: 2017
Filed under: DR-TB, Drug-resistant TB, Guidance and Tools, mdr-tb, multidrug-resistant TB, program management, Treatment, XDR-TB

Management of drug-resistant tuberculosis

Author(s): The Lancet
Year: 2019
Filed under: DR-TB, Drug-resistant TB, mdr-tb, multidrug-resistant TB, Mycobacterium, TB patients, Treatment

National Action Plan for Combating Multidrug-Resistant Tuberculosis

Author(s): U.S. Government
Year: 2015
Filed under: Accountability, Intervention, Interventions, mdr-tb, multidrug-resistant TB, Plan, strategy, USG, XDR-TB

The potential role of garlic (Allium sativum) against the multi-drug resistant tuberculosis pandemic: a review

Author(s): Annali dell’Istituto superiore di sanita
Year: 2011
Filed under: Garlic, Journal Article, mdr-tb, multidrug-resistant TB, Research

E-Health Systems for Management of MDR-TB in Resource-Poor Environments: A Decade of Experience and Recommendations for Future Work

Author(s): IOS Press
Year: 2013
Filed under: Digital Health, Journal Article, mdr-tb, multidrug-resistant TB, Research, Technology

Perspectives on Advances in Tuberculosis Diagnostics, Drugs, and Vaccines

Author(s): Clinical Infectious Diseases
Year: 2015
Filed under: Diagnostics, Journal Article, mdr-tb, multidrug-resistant TB, Rapid tests, Research, Treatment, XDR-TB

Pathways to multidrug-resistant tuberculosis diagnosis and treatment initiation: a qualitative comparison of patients’ experiences in the era of rapid molecular diagnostic tests

Author(s): BMC Health Services Research
Year: 2015
Filed under: Diagnostics, GenoType, Journal Article, mdr-tb, multidrug-resistant TB, Qualitative, Rapid tests, Research, Tests, Treatment, Xpert

Treatment correlates of successful outcomes in pulmonary multidrug-resistant tuberculosis: An individual patient data meta-analysis

Author(s): The Lancet
Year: 2018
Filed under: Journal Article, mdr-tb, multidrug-resistant TB, Research, TB data, TB patients, Treatment

Posts navigation

Older Posts
  • Knowledge Hub
  • Data Hub
TB DIAH Project
University of North Carolina
123 West Franklin Street, Suite 330
Chapel Hill, North Carolina 27516 USA
About
Countries
Topics
Resource Library
News
TB DIAH Digest
Special Features
Assessments
TB Data Hub
Objectives

The TB DIAH project is part of USAID's performance-based measures to end TB—the Global Accelerator to End Tuberculosis. This TB DIAH website features a data hub, guidance, and tools to support the work of the global TB community. TB DIAH makes possible optimal analysis and use of TB data to inform national TB programs, policies, and USAID-supported interventions.

This information was produced with the support of the United States Agency for International Development (USAID) under the terms of the TB Data, Impact Assessment and Communications Hub (TB DIAH) Associate Award No. 7200AA18LA00007. TB DIAH is implemented by the University of North Carolina at Chapel Hill, in partnership with John Snow, Inc. Views expressed are not necessarily those of USAID or the United States government.